Literature DB >> 22176950

Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax.

Jong Ik Kim1, Gyoo Seung Jung, Yu Young Kim, Ga Young Ji, Hyung Seok Kim, Wen Dan Wang, Ho Sun Park, Song Yong Park, Geun Hee Kim, Shi Nae Kwon, Keon Myung Lee, Jin Hyun Ahn, Yeup Yoon, Chan Hee Lee.   

Abstract

BACKGROUND: Varicella-zoster virus (VZV) causes chickenpox in children and shingles in older people. Currently, live attenuated vaccines based on the Oka strain are available worldwide. In Korea, an attenuated VZV vaccine has been developed from a Korean isolate and has been commercially available since 1994. Despite this long history of use, the mechanism for the attenuation of the vaccine strain is still elusive. We attempted to understand the molecular basis of attenuation mechanism by full genome sequencing and comparative genomic analyses of the Korean vaccine strain SuduVax.
RESULTS: SuduVax was found to contain a genome that was 124,759 bp and possessed 74 open reading frames (ORFs). SuduVax was genetically most close to Oka strains and these Korean-Japanese strains formed a strong clade in phylogenetic trees. SuduVax, similar to the Oka vaccine strains, underwent T- > C substitution at the stop codon of ORF0, resulting in a read-through mutation to code for an extended form of ORF0 protein. SuduVax also shared certain deletion and insertion mutations in ORFs 17, 29, 56 and 60 with Oka vaccine strains and some clinical strains.
CONCLUSIONS: The Korean VZV vaccine strain SuduVax is genetically similar to the Oka vaccine strains. Further comparative genomic and bioinformatics analyses will help to elucidate the molecular basis of the attenuation of the VZV vaccine strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22176950      PMCID: PMC3265557          DOI: 10.1186/1743-422X-8-547

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


  21 in total

Review 1.  Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome.

Authors:  B Faga; W Maury; D A Bruckner; C Grose
Journal:  Virology       Date:  2001-02-01       Impact factor: 3.616

2.  Serial propagation in vitro of agents producing inclusion bodies derived from varicella and herpes zoster.

Authors:  T H WELLER
Journal:  Proc Soc Exp Biol Med       Date:  1953-06

3.  A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades.

Authors:  Geoffrey A Peters; Shaun D Tyler; Charles Grose; Alberto Severini; Michael J Gray; Chris Upton; Graham A Tipples
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  The cellular localization pattern of Varicella-Zoster virus ORF29p is influenced by proteasome-mediated degradation.

Authors:  Christina L Stallings; Gregory J Duigou; Anne A Gershon; Michael D Gershon; Saul J Silverstein
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Genetic variation of varicella-zoster virus: evidence for geographical separation of strains.

Authors:  W Barrett-Muir; F T Scott; P Aaby; J John; P Matondo; Q L Chaudhry; M Siqueira; A Poulsen; K Yaminishi; J Breuer
Journal:  J Med Virol       Date:  2003       Impact factor: 2.327

6.  The complete DNA sequence of varicella-zoster virus.

Authors:  A J Davison; J E Scott
Journal:  J Gen Virol       Date:  1986-09       Impact factor: 3.891

7.  Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy.

Authors:  K M Duus; C Hatfield; C Grose
Journal:  Virology       Date:  1995-07-10       Impact factor: 3.616

8.  Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping.

Authors:  Vladimir N Loparev; Antonio Gonzalez; Marlene Deleon-Carnes; Graham Tipples; Helmut Fickenscher; Einar G Torfason; D Scott Schmid
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Varicella-zoster virus (VZV) ORF17 protein induces RNA cleavage and is critical for replication of VZV at 37 degrees C but not 33 degrees C.

Authors:  Hitoshi Sato; Lawrence D Callanan; Lesley Pesnicak; Tammy Krogmann; Jeffrey I Cohen
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

10.  Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system.

Authors:  Zhen Zhang; Jenny Rowe; Weijia Wang; Marvin Sommer; Ann Arvin; Jennifer Moffat; Hua Zhu
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

View more
  13 in total

Review 1.  Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review.

Authors:  Jessica Leung; Karen R Broder; Mona Marin
Journal:  Expert Rev Vaccines       Date:  2017-02-28       Impact factor: 5.217

2.  Characterization and phylogenetic analysis of Varicella-zoster virus strains isolated from Korean patients.

Authors:  Min Ho Kim; Jeong Seon Jeon; In Kyo Kim; Ji Seon Park; Hosun Park; Ok Sarah Shin; Chan Hee Lee
Journal:  J Microbiol       Date:  2017-07-28       Impact factor: 3.422

3.  Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.

Authors:  Ui Yoon Choi; Dong Ho Huh; Jong Hyun Kim; Jin Han Kang
Journal:  Hum Vaccin Immunother       Date:  2016-08-02       Impact factor: 3.452

4.  The comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka.

Authors:  Zuhal Umit; Zumrut Sahbudak Bal; Aysin Zeytinoglu; Tansu Gulbahar Aydogan; Ozlem Bag; Gizem Guner Ozenen; Ferda Ozkinay; Zafer Kurugol
Journal:  Hum Vaccin Immunother       Date:  2021-10-13       Impact factor: 4.526

5.  The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation.

Authors:  Geoffrey A Peters; Shaun D Tyler; John E Carpenter; Wallen Jackson; Yasuko Mori; Ann M Arvin; Charles Grose
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

6.  Bioinformatics of varicella-zoster virus: single nucleotide polymorphisms define clades and attenuated vaccine genotypes.

Authors:  Vincent T Chow; Graham A Tipples; Charles Grose
Journal:  Infect Genet Evol       Date:  2012-11-24       Impact factor: 3.342

7.  Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test.

Authors:  S B Han; K R Kang; D H Huh; H C Lee; J H Kim; J H Kang; S H Ma
Journal:  Epidemiol Infect       Date:  2014-09-19       Impact factor: 2.451

8.  Standardization of the methods and reference materials used to assess virus content in varicella vaccines.

Authors:  JiYoung Hong; Ho Jung Oh; Naery Lee; Do-Keun Kim; Heui-Seong Yoon; Yeon-Tae Kim; Seokkee Chang; Jae-Hak Park; Hyejoo Chung
Journal:  Virol J       Date:  2015-07-05       Impact factor: 4.099

9.  Comparison of the Whole-Genome Sequence of an Oka Varicella Vaccine from China with Other Oka Vaccine Strains Reveals Sites Putatively Critical for Vaccine Efficacy.

Authors:  Qiuhua Wu; Pierre Rivailler; Songtao Xu; Wenbo Xu
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

10.  Deep Sequencing of Distinct Preparations of the Live Attenuated Varicella-Zoster Virus Vaccine Reveals a Conserved Core of Attenuating Single-Nucleotide Polymorphisms.

Authors:  Daniel P Depledge; Koichi Yamanishi; Yasuyuki Gomi; Anne A Gershon; Judith Breuer
Journal:  J Virol       Date:  2016-09-12       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.